The treatments weren’t part of a randomized trial, so it can’t be said with certainty that they caused the patients’ viral clearance. The authors suggested that interferon gamma should be studied as an adjuvant therapy for severely immunocompromised patients whose persistently high SARS-CoV-2...
Objective To assess the growing number of reports of clinical experiences of patients with COVID-19 who are immunocompromised and treated with specific neutralizing antibodies via COVID-19 convalescent plasma transfusion. Data Sources On August 12, 2022, a systematic search was performed for clinical ...
Recently, there has been a dramatic rise in COVID-19 hospitalizations due to the highly contagious Delta variant. According to the Centers for Disease Control and Prevention's (CDC) COVID Data Tracker Weekly Review, vaccinated immunocompromised people are more likely to have breakthrough infections ...
Abbvie, Novartis, Merrimack, OmniSeq, PGDx, Merck, Mirati, Astellas, and Regeneron; consulting/speaking with Genentech Roche, Exelixis, Genomic Health, and Sanofi Aventis; and consulting/advisory board with AstraZeneca, Bayer, Pfizer, Foundation Medicine, Janssen, Amgen, BMS, Calithera, Dendreon, ...
Sep 29, 2020Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Older Adult Age Cohorts in Phase 1 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273) Aug 11, 2020Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses...
Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal Helena F. Florindo, Rita C. Acúrcio & Barbara Carreira Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel ...
Introduction: Immunocompromised patients are at increased risk of contracting severe COVID-19 infection. The purpose of this study was to assess COVID-19 v... B Lazarevic,AR Casola,CV Chambers - 《Journal of the American Board of Family Medicine Jabfm》 被引量: 0发表: 2023年 加载更多来源...
Medicine.com guides (external) COVID-19 Guide Sources About COVID-19. June 13, 2024. US Centers for Disease Control and Prevention (CDC). Accessed Sept 10, 2024 at https://www.cdc.gov/covid/about/index.html IDSA Guidelines on the Treatment and Management of Patients with COVID- 8/12...
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study EClinicalMedicine, 61 (2023), Article 102040 View PDFView articleView in ScopusGoogle Scholar [20] F. Amanat, D. Stadlbauer, S. Strohmeier, T.H.O. Nguyen, V. Chromikov...
Patients with haematological malignancies have a higher risk of developing reduced immune responses to COVID-19 vaccination65,100,109,110,120,125,129and, as found in a large-cohort study in the USA, also show a lower VE (VE 74% versus 90% in non-immunocompromised individuals)111. Encouraging...